# Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer

> **NCT00265200** · PHASE2 · TERMINATED · sponsor: **University of Louisville** · enrollment: 28 (actual)

## Conditions studied

- Carcinoma, Non-Small Cell Lung
- Carcinoma, Small Cell Lung
- Metastases

## Interventions

- **DRUG:** zoledronic acid

## Key facts

- **NCT ID:** NCT00265200
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-02
- **Primary completion:** 2009-08
- **Final completion:** 2010-12
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** funding discontinued by sponsor
- **Last updated:** 2018-03-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00265200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00265200, "Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00265200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*